These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31546257)

  • 1. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
    Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
    Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
    Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
    Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.
    Steer KJ; Sun Z; Sadowski DC; Yong JHE; Coldman A; Nemecek N; Yang H
    J Med Screen; 2024 Jun; 31(2):78-84. PubMed ID: 37728194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 8. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.
    Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M
    JAMA; 2015 Jun; 313(23):2349-58. PubMed ID: 26080339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
    Cross AJ; Wooldrage K; Robbins EC; Kralj-Hans I; MacRae E; Piggott C; Stenson I; Prendergast A; Patel B; Pack K; Howe R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran SP; Atkin WS
    Gut; 2019 Sep; 68(9):1642-1652. PubMed ID: 30538097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
    Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
    Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.
    van Hees F; Habbema JD; Meester RG; Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG
    Ann Intern Med; 2014 Jun; 160(11):750-9. PubMed ID: 24887616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps.
    Zorzi M; Battagello J; Amidei CB; Antonelli G; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rizzotto ER; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rugge M; ; Hassan C
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1518-1527.e7. PubMed ID: 38325601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.
    Dinh TA; Alperin P; Walter LC; Smith R
    J Gen Intern Med; 2012 Jun; 27(6):730-8. PubMed ID: 22237663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
    Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
    Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
    Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
    Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of screening strategies for colorectal cancer.
    Barzi A; Lenz HJ; Quinn DI; Sadeghi S
    Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
    van Hees F; Saini SD; Lansdorp-Vogelaar I; Vijan S; Meester RG; de Koning HJ; Zauber AG; van Ballegooijen M
    Gastroenterology; 2015 Nov; 149(6):1425-37. PubMed ID: 26253304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.